Survey details ongoing shortage of cancer medications
A survey released Sept. 10 by the National Comprehensive Cancer Network highlights ongoing shortages of cancer medications. All responding cancer centers reported a shortage of at least one anti-cancer agent, with more than 20% currently experiencing a shortage of five or more medications. Of particular note, 94% of respondents indicated a critical shortage of ifosfamide — a generic drug used to treat a variety of cancers — and 71% reported a shortage of the cancer-treating drug carboplatin.
Related News Articles
Headline
A study released Nov. 5 by the National Institutes of Health found that women with higher blood levels of two common per- and polyfluoroalkyl substances, or…
Headline
The Administration for Strategic Preparedness and Response announced Nov. 3 that it will partner with the Bureau of Industry and Security and the Assistant…
Headline
The Department of Labor Oct. 29 finalized a rule designed to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to…
Headline
A study conducted by the University of Utah examined variations in risk behaviors for colorectal, cervical and breast cancer and trends in screening across…
Headline
The Department of Health and Human Services Oct. 27 announced a new initiative to improve breast cancer screening and detection efforts. The initiative, led by…
Headline
The median annual net launch price for new prescription drugs increased 35% from 2022 to 2025, to $257,000, according to a report released by the Institute for…